DOWNLOAD CATALOGUE
Our Company
Our Identity
Who we are
Our History
Our Philosophy
Our Numbers
Our Corporate Structure
Our Divisions
Our Sites
Our Management
Our People
Our Partnerships
Our International Presence
Our Exports
International Licensing
Our Subsidiaries
DIAGNOZ Plc
Strategy & Investments
Our Strategy
Our PHARMAZAC 50 Vision
Our Research & Development
New Sites Projects
Our Science
Generic Pharmaceuticals (Gx)
Generics
Our R&D Laboratories
Our Projects
Innovative Generics (Gx+)
Our Innovation Strategy
Our Innovative Projects
Diagnostics &
Radiopharmaceuticals (PDx)
Contrast Media
Nuclear Medicine
Radiopharmaceuticals
Theranostics
Pharma Manufacturing & QC
Solid Forms
Nasal Sprays
Sterile (Radiopharma)
Logistics Operations
Quality Control & Release Labs
Our Products & Services
Our Products in Greece
Our International Dossiers
Our Diagnostics
Our News Hub
Your Career
Contact
EN
0
$0.00
✕
MARKET AVAILABILITY
ARNI + SGLT2 Inhibitor Combination Therapy
Home
Product PHARMACOLOGICAL CLASS
ARNI + SGLT2 Inhibitor Combination Therapy
THERAPEUTIC AREA
-
Allergy
Anesthesiology
Cardio-Renal-Metabolic (CRM)
Cardiology / Diagnostic imaging
Cardiovascular
Cardiovascular / Antithrombotic therapy
Cardiovascular / Cardiology
Cardiovascular / Dyslipidemia
Cardiovascular / Hypertension
Chronic Kidney Disease
Endocrinology
Endocrinology / Bone metabolism
Endocrinology / Diabetes
Hepatology / MASH
Infectious diseases
Iron deficiency
Menopause
Musculoskeletal disorders
Nephrology
Neurology
Neurology / Alzheimer's disease
Neurology / Epilepsy
Neurology / Parkinson's disease
Neurology / Peripheral neuropathy
Obstetrics
Oncology
Oncology / Endocrinology
Oncology / Hematology
Oncology / Urology
Psychiatry
Psychiatry / Neurology
Radiology / Diagnostic imaging
Radiology / MRI contrast enhancement
PHARMACOLOGICAL CLASS
+
Acetylcholinesterase inhibitor
Aldosterone Receptor Antagonist
Alzheimer’s disease
Anticoagulant
Antidepressant
Antidote / Biochemical modulator
Antiepileptic
Antihyperlipidemic
Antihypertensive
Antimigraine
Antineoplastic
Antiplatelet
Antipsychotic
ARNI + SGLT2 Inhibitor Combination Therapy
Aromatase inhibitor
Biological lubricant
Bisphosphonate
Calcimimetic
Cardiac Myosin Inhibitor
Cholinesterase inhibitor
Coronary vasodilator
Diagnostic
DPP‑4 inhibitor
Echinocandin antifungal
Folate analogue
GnRH agonist
Hypnotic
Immunotherapy
Iron supplement
Leukotriene receptor antagonist
Monoamine oxidase type B (MAO‑B) inhibitor
NK-3 Receptor Antagonist
Oral hypoglycemic
Pyrimidine synthesis inhibitor
Selective relaxant binding agent (SRBA)
SGLT-2 Inhibitor
Skeletal muscle relaxant
Thyroid Hormone Receptor-beta (THR-β) Agonist
Vitamin B complex
Vitamin D
BUSINESS UNIT
+
CNS
Contrast Media Agents
Oncology
Primary Care
Radiopharmaceutical
ACTIVE SUBSTANCE
+
Abiraterone
Agomelatine
Aledronate
Amlodipine/Valsartan
Apixaban
Aripiprazole
Atorvastatin
Bacillus Calmette-Guerin
Baclofen
Bempedoic acid
Bempedoic acid / Ezetimibe
Brexpiprazole
Brivaracetam
Calcium Folinate
Capecitabine
Cholecalciferol
Cinacalcet
Clopidogrel
Dapagliflozin
Dapagliflozin/Metformin
Daridorexant
Donepezil
Duloxetine
Edoxaban
Everolimus
Exemestane
Ezetimibe/Atorvastatin
Ezetimibe/Simvastatin
Ferric carboxymaltose
Ferrous Gluconate
Fezolinetant
Finerenone
Folinic Acid
Gadobutrol
Gadoteric Acid
Hyaluronate Sodium
Iodixanol
Iohexol
Iron sucrose
Letrozole
Leuprorelin
Levetiracetam
Linagliptin
Linagliptin/Metformin
Losartan/Hydrochlorothiazide
Lurasidone
Mavacamten
Memantine
Micafungin
Montelukast
Nebivolol
Olanzapine
Paliperidone
Perflutren
Pitavastatin
Pravastatin/Fenofibrate
Quetiapine
Rasagiline
Regadenoson
Resmetirom
Rivaroxaban
Rivastigmine
Rosa canina
Rosuvastatin
Rosuvastatin/Ezetimibe
Sacubitril
Safinamide mesylate
Sitagliptin
Sitagliptin/Metformin
Sugammadex
Sumatriptan
Teriflunomide
Thiamine/Pyridoxine/Cyanocobalamin
Ticagrelor
Topiramate
Valsartan
Valsartan/Hydrochlorothiazide
Venlafaxine
Vinorelbine
Vortioxetine
PRESCRIPTION REQUIREMENT
+
OTC (over-the-counter)
Rx (prescription required)
MARKETING AUTHORISATION HOLDER
+
GE Healthcare A.S.
Krka d.d.
Laboratoires Servier Industrie
Laboratoires SMB S.A.
Pharmazac S.A.
Provident Pharmaceuticals Ltd
Synthaverse S.A.
TAD Pharma GmbH
Sacubitril + Valsartan + Dapagliflozin
0
$0.00
No translations available for this page
✕
Login
Username or email
*
Password
*
Remember me
Login
Lost your password?
Learn More
